United Services Automobile Association Takes Position in Avantor, Inc. (NYSE:AVTR)

United Services Automobile Association bought a new stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 44,498 shares of the company's stock, valued at approximately $1,151,000.

Other institutional investors also recently bought and sold shares of the company. Cetera Advisors LLC acquired a new position in shares of Avantor in the first quarter worth $249,000. SG Americas Securities LLC raised its position in Avantor by 222.0% in the 2nd quarter. SG Americas Securities LLC now owns 19,996 shares of the company's stock valued at $424,000 after purchasing an additional 13,786 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Avantor by 2.8% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company's stock valued at $571,000 after buying an additional 733 shares during the period. ORG Partners LLC grew its position in shares of Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company's stock worth $122,000 after buying an additional 5,773 shares in the last quarter. Finally, PGGM Investments purchased a new stake in shares of Avantor during the second quarter worth approximately $238,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of AVTR stock traded up $0.55 during trading hours on Friday, hitting $21.39. The company's stock had a trading volume of 5,379,971 shares, compared to its average volume of 6,741,872. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The business has a fifty day moving average of $22.78 and a 200-day moving average of $23.58. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00. The stock has a market cap of $14.56 billion, a price-to-earnings ratio of 46.50, a P/E/G ratio of 2.57 and a beta of 1.29.

Wall Street Analyst Weigh In

AVTR has been the subject of a number of recent research reports. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research note on Monday, October 28th. Royal Bank of Canada reiterated an "outperform" rating and set a $34.00 target price on shares of Avantor in a research note on Thursday, September 26th. Barclays cut their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Friday, October 25th. Wells Fargo & Company decreased their price target on Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Finally, UBS Group dropped their price objective on Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a report on Tuesday, October 8th. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $27.69.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.